3rd Quarter - Report
BOCKORNY GROUP, INC. for GENERIC PHARMACEUTICAL ASSOCIATION
Firm
Income
$30,000
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
H.R.3204, Drug Quality and Security Act S.957, Drug Supply Chain Security Act S.959, Pharmaceutical Quality, Security, and Accountability Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BOCKORNY New | — |
| MARTINA L. BRADFORD New | — |
| BLAIR C LARKINS New | — |
| TODD THORPE New | — |
| NICOLE VENABLE New | — |
Medicare/Medicaid MMM
Issues Relating to Medicare Part D
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BOCKORNY New | — |
| MARTINA L. BRADFORD New | — |
| BLAIR C LARKINS New | — |
| TODD THORPE New | — |
| NICOLE VENABLE New | — |
Copyright/Patent/Trademark CPT
Issues relating to Patent Settlements.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BOCKORNY New | — |
| MARTINA L. BRADFORD New | — |
| BLAIR C LARKINS New | — |
| TODD THORPE New | — |
| NICOLE VENABLE New | — |
Health Issues HCR
H.R. 3204, Drug Quality and Security Act H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013 S. 214, Preserve Access to Affordable Generics Act S. 504, Fair And Immediate Release of Generic Drugs Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BOCKORNY New | — |
| MARTINA L. BRADFORD New | — |
| BLAIR C LARKINS New | — |
| TODD THORPE New | — |
| NICOLE VENABLE New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.